Jump Financial’s Adicet Bio ACET Stock Holding History

Jump Financial’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.5K	Buy	+10,942	New	+$86.2K	﹤0.01%	1906
2023 Q3	–	Sell	-3,721	Closed	-$145K	–	1791
2023 Q2	$145K	Buy	3,721 +1,140	+44%	+$101K	0.01%	1589
2023 Q1	$238K	Buy	+2,581	New	+$324K	0.01%	1234
2022 Q3	–	Sell	-731	Closed	-$171K	–	1525
2022 Q2	$171K	Sell	731 -732	-50%	-$161K	0.01%	1345
2022 Q1	$467K	Sell	1,463 -768	-34%	-$177K	0.02%	846
2021 Q4	$624K	Buy	+2,231	New	+$383K	0.04%	560
2021 Q3	–	Sell	-831	Closed	-$137K	–	1054
2021 Q2	$137K	Buy	+831	New	+$169K	0.01%	942

Other funds holding ACET

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Jump Financial's ACET Position: Q2 2026 in Review

Jump Financial opened a new position in Adicet Bio (ACET) in Q2 2026: 10,942 shares worth $94.5K. The stake represents ﹤0.01% of the portfolio and ranks #1906 among its holdings. This is a return to the name: Jump Financial previously reported a position in ACET as recently as Q2 2023.

Jump Financial first reported a position in ACET in Q2 2021 and has held it in 7 quarters since. The position peaked at $624K in Q4 2021. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

Jump Financial held 10,942 shares of Adicet Bio worth $94.5K as of Q2 2026.
Adicet Bio was a new Jump Financial position in Q2 2026.
Adicet Bio made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1906 holding.
Jump Financial first reported a position in Adicet Bio in Q2 2021 and has held it in 7 quarters since.
Jump Financial's Adicet Bio position peaked at $624K in Q4 2021.
56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.